Dissertation > Excellent graduate degree dissertation topics show

Studying the Relationship of Inflammation Network and Thrombophilia in SLE and Traditional Chinese Medicine and Western Medicine Intervene It’s Effect

Author: KangLiLi
Tutor: GuJian
School: Yangzhou University
Course: Traditional Chinese Medicine
Keywords: Systemic Lupus Erythematosus Inflammatory adhesion molecules Endothelial cells and platelet activation Thrombophilia Safflower injection
CLC: R593.241
Type: Master's thesis
Year: 2009
Downloads: 31
Quote: 0
Read: Download Dissertation

Abstract


Objective: To study the inflammatory network and endothelial cells, platelet activating impact of SLE autoimmune of thrombophilia pathological process, safflower injection combined with Western medicine for SLE thrombophilic state intervention to provide a theoretical basis for traditional Chinese medicine to treat immune thrombophilia . Method: observation of 85 patients with systemic lupus erythematosus (systemic lupus erythematosus, SLE) patients, including mitigation of 31 cases, the activities of 54 cases. Observed by enzyme-linked immunosorbent assay (ELISA) interleukin -6 (interleukin-6, IL-6), IL-8, IL-10, IL-18, soluble thrombomodulin protein (solubility thrombomodulin sTM), soluble vascular cell adhesion molecule -1 (solubility vascular cell adhesion molecule-1, sVCAM-1) and flow cytometry (flow cytometry, FCM) to detect neutrophils of CD11b, P-selectin (CD62p), platelet-activating membrane glycoprotein Ⅱ b / Ⅲ a binding sites (PAC-1) and other inflammatory adhesion factor, vascular endothelial cells and platelet-activating factor expression. Results: 1 inflammatory adhesion molecules IL-6, IL-8, IL-10, IL-18 and CD11b expression (P lt; 0.05) in SLE patients with active are abnormally high levels, such factor levels in disease remission When close to normal controls (P gt; 0.05). 2, vascular endothelial cell activating factor sTM and sVCAM-1 levels in the serum of patients with active SLE was significantly higher than in remission and the control group (P lt; 0.05), ease the control group, no differences (P gt; 0.05). SLE patients with active platelet-activating factor CD62p levels were significantly higher (P lt; 0.05), remission restore nearly normal (P gt; 0.05). PAC-1 compared with the control group increased in SLE patients with active and remission, but no significant change (P gt; 0.05). Conventional western medicine treatment in patients with active SLE, IL-6, IL-8, IL-10, IL-18, CD11b, of sTM, sVCAM-1 and CD62p levels than before treatment were significantly decreased (P lt; 0.05) . Safflower injection combined with conventional western medicine, the indicators are lower than before treatment with conventional western medicine treatment group (P lt; 0.05). Conclusion: SLE with active presence of the abnormal inflammation adhesion factor release, induce or aggravate pathological basis of immune inflammatory thrombophilia. Pathological endothelial cell activation and platelet activation is involved in active SLE one of the important factors for thrombophilia. 3, the conventional western medicine, traditional Chinese medicine safflower combined with Western medicine treatment programs can effectively alleviate the SLE disease improve immune inflammatory suppository state; Chinese drug saffron significant than with Western medicine combined with Western.

Related Dissertations

  1. Clinical Analysis of 33 Cases of Pediatric Systemic Lupus Erythematosus,R725.9
  2. OX40/OX40L peripheral blood lymphocytes in patients with SLE characteristics and biological significance of the expression,R593.241
  3. Changes of the Metalloprotease That Cleaves Von Willebrand Factor in Women During Normal Pregnancy and Other Diseases Like Gestational Hypertension,R714.25
  4. Genetic Variation in CD226 Gene and Systemic Lupus Erythematosus,R593.241
  5. Systemic lupus erythematosus CD4 ~ T cell IL-10 and IL-13 gene methylation status of regulatory sequences,R593.241
  6. Aplication and Development of Cystatin C Kit,R593.241
  7. Analysis on Health-related Quality of Life in Patients with Systemic Lupus Erythematosus,R593.241
  8. The Relationship among Serum Thrombopoietin、C-Mpl and Systemic Lupus Erythematosus,R593.241
  9. The Study of Levels of Toll-like Receptor 9 and IL-10、 IFN-α in Patients with Systemic Lupus Erythematosus,R593.241
  10. The application of the theory of collateral disease in systemic lupus erythematosus,R259
  11. Expression of Nuerogranin、CAMK2 and CAMK4 in Peripheral Blood Mononuclear Cells in Patients with Systemic Lupus Erythematosus,R593.241
  12. Left ventricular function in patients with systemic lupus erythematosus ultrasound imaging studies,R445.1
  13. Clinical Observation on the Integrating Treatment of Lupus Nephritis in Mildly or Moderately Active Stage with Traditional Chinese and Western Medicine,R593.242
  14. PLNPK Ameliorated Experimental Systemic Lupus Erythematosus by Inhibiting the Activation of B Lymphocytes,R593.241
  15. Clinical Analysis of Renal Injury by Systemic Lupus Erythematosus,R593.241
  16. A Study of the Expression of Lipid Raft/GM1 in Peripheral Blood T Cell and Its Correlation with Cytokines in SLE Patients,R593.241
  17. Level of T-bet, GATA3 and FOXP3 mRNA Expression on the Peripheral Blood Mononuclear Cells of Patients with Systemic Lupus Erythematosus and Its Significance,R593.241
  18. Investigatation of the Relationship between TCM Syndrome Type and Laboratory Indexes in Patients with Systemic Lupus Erythematosus,R259
  19. The Auto-antibodies on Bone Marrow Hematopoietic Cell in Patients with Systemic Lupus Erythematosus,R593.241
  20. Metabolic Syndrome in Chinese Patients with Systemic Lupus Erythematosus,R593.241
  21. Lupus Decoction Integrative treatment of systemic lupus erythematosus 150 cases of long-term efficacy analysis,R593.241

CLC: > Medicine, health > Internal Medicine > Systemic disease > Autoimmune diseases > Autoimmune diseases, connective tissue disease > Lupus erythematosus > Systemic lupus erythematosus
© 2012 www.DissertationTopic.Net  Mobile